← Leaderboards
Terrence Town
Yale University
$5,181,578
Attributed
$5,365,806
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $834.7K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$5,365,806 · 7
By mechanism
R01$3,094,312 · 1
R21$848,513 · 2
R00$789,509 · 1
RF1$412,500 · 1
F32$130,972 · 1
K99$90,000 · 1
Top collaborators
- Clive Niels Svendsen1 shared
Most similar at Yale University
Same institution · by research overlap
- John Greally$14,293,659
- Eric G Pamer$34,388,771
- Lauren E Cohn$6,596,720
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseCellsBrainImmuneSignal TransductionMouse ModelPathologyAmericanTransforming Growth Factor BetaCytokineAmyloidMacrophageAgedTransgenic MiceTransgenic OrganismsEncephalitisDepositionPhenotypePeripheralElderlyTg2576MemoryPathway Interactions
Grant awards (22)
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$621,456
R01 · FY2018 · NS · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$628,497
R01 · FY2017 · NS · contact PI
Rebalancing Innate Immunity in Alzheimer's disease by deleting IRAK-M$206,250
R21 · FY2017 · AG · contact PI
Rebalancing Innate Immunity in Alzheimer's disease by deleting IRAK-M$247,500
R21 · FY2016 · AG · contact PI
T cell TGF-beta signaling as a therapeutic target for pediatric brain tumors$179,438
R21 · FY2016 · CA · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$50,000
R01 · FY2016 · NS · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$360,938
R01 · FY2015 · NS · contact PI
T cell TGF-beta signaling as a therapeutic target for pediatric brain tumors$215,325
R21 · FY2015 · CA · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$356,425
R01 · FY2014 · NS · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$346,370
R01 · FY2013 · NS · contact PI
An iPS Disease-in-a-Dish Model of Familial Alzheimers$368,456
RF1 · FY2012 · AG · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$365,313
R01 · FY2012 · NS · contact PI
An iPS Disease-in-a-Dish Model of Familial Alzheimers$44,044
RF1 · FY2012 · AG · contact PI
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats$365,313
R01 · FY2011 · NS · contact PI
Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseas$246,510
R00 · FY2010 · AG · contact PI
Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseas$44,999
R00 · FY2010 · AG · contact PI
Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseas$249,000
R00 · FY2009 · AG · contact PI
Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseas$249,000
R00 · FY2008 · AG · contact PI
Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseas$90,000
K99 · FY2007 · AG · contact PI
A conditional mouse model of Alzheimer's disease$48,296
F32 · FY2005 · AG
A conditional mouse model of Alzheimer's disease$42,976
F32 · FY2004 · AG
A conditional mouse model of Alzheimer's disease$39,700
F32 · FY2003 · AG